Laurent G - Search Results

1

Rituximab inhibits B-cell receptor signaling.

Kheirallah S, Caron P, Gross E, Quillet-Mary A, Bertrand-Michel J, Fournié JJ, Laurent G, Bezombes C. Kheirallah S, et al. Among authors: laurent g. Blood. 2010 Feb 4;115(5):985-94. doi: 10.1182/blood-2009-08-237537. Epub 2009 Nov 17. Blood. 2010. PMID: 19965664 Free article.

2

Protein kinase Czeta mediated Raf-1/extracellular-regulated kinase activation by daunorubicin.

Mas VM, Hernandez H, Plo I, Bezombes C, Maestre N, Quillet-Mary A, Filomenko R, Demur C, Jaffrézou JP, Laurent G. Mas VM, et al. Among authors: laurent g. Blood. 2003 Feb 15;101(4):1543-50. doi: 10.1182/blood-2002-05-1585. Epub 2002 Oct 24. Blood. 2003. PMID: 12406911 Free article.

3

Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains.

Bezombes C, Grazide S, Garret C, Fabre C, Quillet-Mary A, Müller S, Jaffrézou JP, Laurent G. Bezombes C, et al. Among authors: laurent g. Blood. 2004 Aug 15;104(4):1166-73. doi: 10.1182/blood-2004-01-0277. Epub 2004 May 4. Blood. 2004. PMID: 15126316 Free article.

4

Syk-dependent mTOR activation in follicular lymphoma cells.

Leseux L, Hamdi SM, Al Saati T, Capilla F, Recher C, Laurent G, Bezombes C. Leseux L, et al. Among authors: laurent g. Blood. 2006 Dec 15;108(13):4156-62. doi: 10.1182/blood-2006-05-026203. Epub 2006 Aug 15. Blood. 2006. PMID: 16912221 Free article.

5

PKC zeta mTOR pathway: a new target for rituximab therapy in follicular lymphoma.

Leseux L, Laurent G, Laurent C, Rigo M, Blanc A, Olive D, Bezombes C. Leseux L, et al. Among authors: laurent g, laurent c. Blood. 2008 Jan 1;111(1):285-91. doi: 10.1182/blood-2007-04-085092. Epub 2007 Sep 12. Blood. 2008. PMID: 17855629 Free article.

6

Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.

Gertner-Dardenne J, Bonnafous C, Bezombes C, Capietto AH, Scaglione V, Ingoure S, Cendron D, Gross E, Lepage JF, Quillet-Mary A, Ysebaert L, Laurent G, Sicard H, Fournié JJ. Gertner-Dardenne J, et al. Among authors: laurent g. Blood. 2009 May 14;113(20):4875-84. doi: 10.1182/blood-2008-08-172296. Epub 2009 Mar 10. Blood. 2009. PMID: 19278954 Free article.

7

Direct effect of rituximab in B-cell-derived lymphoid neoplasias: mechanism, regulation, and perspectives.

Bezombes C, Fournié JJ, Laurent G. Bezombes C, et al. Among authors: laurent g. Mol Cancer Res. 2011 Nov;9(11):1435-42. doi: 10.1158/1541-7786.MCR-11-0154. Epub 2011 Sep 15. Mol Cancer Res. 2011. PMID: 21921050 Review.

8

Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukemic cells.

de Thonel A, Bettaïeb A, Jean C, Laurent G, Quillet-Mary A. de Thonel A, et al. Among authors: laurent g. Blood. 2001 Dec 15;98(13):3770-7. doi: 10.1182/blood.v98.13.3770. Blood. 2001. PMID: 11739185 Free article.

9

Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation.

Bezombes C, de Thonel A, Apostolou A, Louat T, Jaffrézou JP, Laurent G, Quillet-Mary A. Bezombes C, et al. Among authors: laurent g. Mol Pharmacol. 2002 Dec;62(6):1446-55. doi: 10.1124/mol.62.6.1446. Mol Pharmacol. 2002. PMID: 12435813

10

Implication of raft microdomains in drug induced apoptosis.

Bezombes C, Laurent G, Jaffrézou JP. Bezombes C, et al. Among authors: laurent g. Curr Med Chem Anticancer Agents. 2003 Jul;3(4):263-70. doi: 10.2174/1568011033482413. Curr Med Chem Anticancer Agents. 2003. PMID: 12769772 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,132 results

Search Page

Filters